CJC-1295 No DAC + Ipamorelin is a research peptide blend combining a modified growth
hormone-releasing hormone (GHRH) analog with a selective growth hormone secretagogue
peptide.
It is commonly investigated in peptide and endocrine research environments involving growth
hormone signaling, receptor-pathway interaction, IGF-1-related research, and pituitary-regulatory
mechanisms.
GENYX CJC-1295 No DAC + Ipamorelin is supplied as a high-purity lyophilized peptide blend and
independently verified for identity and purity standards.
For research use only. Not intended for human or veterinary application
| Compound | CJC-1295 No DAC + Ipamorelin |
|---|---|
| Form | Lyophilized Powder |
| Purity | ≥98% (HPLC Verified) |
| Verification | Third-Party Tested |
| Quantity | 5mg CJC-1295 No DAC + 5mg Ipamorelin |
| Total Quantity | 10mg, 10mg pack of 3 |
| Storage | Frozen Recommended |
CJC-1295 No DAC + Ipamorelin is an investigational peptide blend commonly explored in research involving:
Not for human consumption.
Superior stability and shelf life.
≥98% (HPLC Verified)
This product is intended strictly for laboratory research use only. Not for human consumption. Not for veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. By purchasing, the customer acknowledges responsibility for compliance with all applicable local laws, regulations, and research handling requirements.
Build a complete research stack.





This product has been verified and is awaiting publicationof the latest batch testing information.
